AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (5.7 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Research Article | Open Access | Just Accepted

Dual-engine ferroptosis initiation via a hypoxia-responsive nanoplatform for colorectal cancer immunotherapy

Chengyuan Cai1,§, Xuming Chen2,§, Honglei Hu1,§, Zeyang Qiu1, Yuanhao Chen1, Jun Chen1, Pei Huang2, Jiaxiang Wu2, Zhiwei Duan3, Yi Zhou2( ), He Wang1( )

1 Guangzhou Key Laboratory for Research and Development of Nano-Biomedical Technology for Diagnosis and Therapy and Guangdong Provincial Education Department Key Laboratory of Nano-Immunoregulation Tumor Microenvironment, Department of Oncology, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou 510260, China

2 The Fifth Affiliated Hospital, Key Laboratory of Molecular Target and Clinical Pharmacology and the State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, China

3 School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China

§ These authors contributed equally to this work.

Show Author Information

Abstract

Despite the promise of immunotherapy for colorectal cancer (CRC), efficacy is limited by an immunosuppressive microenvironment that resists single-modality interventions. Herein, we propose a dual‑engine ignition strategy for ferroptosis using a hypoxia‑responsive gadolinium‑coordination nanoplatform (PAD@CR) prepared via a one‑pot reaction among Gd³⁺, chlorin e6 (Ce6), retinoic acid (RA), and hypoxia‑sensitive PEG. This platform integrates two coordinated engines in a single system: Ce6 serves as the oxidative engine, generating ROS upon ultrasound activation, while RA acts as the brake‑release engine, inhibiting glycolysis to deplete NADPH and GSH, thereby dismantling the antioxidant defense. The convergence of these two orthogonal inputs overwhelms redox homeostasis and triggers immunogenic ferroptosis. The resulting DAMPs establish a positive feedback loop with α‑PD‑L1 therapy, promoting CD8⁺ T cell infiltration and long‑term immunological memory. Notably, IFN‑γ from activated T cells further suppresses GPX4, amplifying ferroptosis in a closed‑loop manner. In vivo, this dual‑engine ignition significantly inhibits tumor growth and extends survival without systemic toxicity. With scalable synthesis, integrated imaging‑therapy functions, and the ability to convert "cold" tumors into "hot" lesions, this nanoplatform offers a translatable strategy to overcome immunotherapy resistance in CRC.

References

【1】
【1】
 
 
Nano Research

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Cai C, Chen X, Hu H, et al. Dual-engine ferroptosis initiation via a hypoxia-responsive nanoplatform for colorectal cancer immunotherapy. Nano Research, 2026, https://doi.org/10.26599/NR.2026.94909314
Topics:

142

Views

24

Downloads

0

Crossref

0

Web of Science

0

Scopus

0

CSCD

Received: 15 August 2026
Revised: 04 November 2026
Accepted: 06 November 2026
Available online: 06 November 2026

© The Author(s) 2026. Published by Tsinghua University Press.

This is an open access article under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0, https://creativecommons.org/licenses/by/4.0/)